23andMe

» see 23andme.com as it lived, on the wayback machine

~ the obit ~

You mailed a tube of your own spit to a lab in California and waited a few weeks for a website to tell you where your ancestors came from. i never did. The whole ritual was coded American, or at least anglophone, in a way that never reached Turkey at any real scale. The kit was priced in dollars and the health reports were knotted into US medical regulation. Couriering your own DNA across an ocean to find out you were a bit Balkan was never going to be a Tuesday-afternoon purchase in Ankara.

the shape of it is not hard to read. 23andMe launched in April 2006 out of Mountain View, started by Anne Wojcicki and Linda Avey. The product was one clean idea, a saliva kit you spat into and sent back, and a few weeks later a login that turned your genome into ancestry percentages and a list of traits you might carry. Time called it the invention of the year in 2008. For a while it was the friendly face of consumer genetics, the thing that made a genome feel like a party trick instead of a lab result.

The trouble was always what sits under a party trick made of medical data. In November 2013 the FDA sent a warning letter and ordered the company to stop marketing the health side of the service, saying it had not proven the results were sound. The health reports went dark for two years and only came back, piece by piece, once regulators signed off on specific ones. The ancestry business carried the company through, and in June 2021 it went public through a SPAC at a three and a half billion dollar valuation, briefly worth around six billion.

Then the floor gave way. The core problem was that a DNA test is something you buy once, so growth kept needing new customers the company could not find fast enough. In October 2023 attackers walked through the front door with reused passwords and pulled data touching nearly seven million people. Trust never recovered. On 23 March 2025 the company filed for Chapter 11, Wojcicki stepped down as chief executive, and the most valuable thing in the estate was the genetic data of everyone who had ever spat in a tube. Her nonprofit later bought the assets back for three hundred and five million dollars.

~ the rap sheet ~

~ the pitch ~

The sell was that your genome should belong to you and be readable by you, not locked inside a hospital. That was a genuinely good pitch in 2007, and it pulled in millions of people who wanted the ancestry number and stayed curious about the health flags. What most of them did not weigh, because nobody weighs it at the checkout, was that they were also handing a private company a permanent, un-changeable record of themselves, and quietly opting into research on top of it. The database, not the kit, was the real business.

~ what really happened ~

It did not end in a scandal of science, it ended in plain corporate collapse. The revenue never found a second act, and an attempt to build a drug-development arm off the data only burned money. The breach turned the brand from cool into risky almost overnight. Once the market cap fell from billions to a rounding error, bankruptcy was arithmetic. The interesting part is only that the failing asset was people.

~ what got buried with it ~

When a bank fails, its loans get sold to whoever buys the wreck. When 23andMe failed, the thing on the block was fourteen million genomes, and regulators in several states had to remind everyone out loud that this data could change hands in a bankruptcy sale. Wojcicki's nonprofit ended up the buyer, which calmed the immediate panic. But the lesson outlived the drama, and it is a cold one. You can delete an account. You cannot un-mail the spit, and the copy you sent away does not answer to you once the company that holds it stops existing.

@}-->--

              )
             (_)
            .-'-.
            |   |
            |   |
            |   |
            |   |
          __|   |__   .-.
       .-'  |   |  `-:   :
      :     `---'     :-'
       `-._       _.-'
           '""""""

« previous  ·  random  ·  next »